Aggregated
60% success rate- Bullish
- 0
- Hold
- 0
- Bearish
- 0
Morgan Stanley
A Morgan Stanley analyst with 11 tracked ratings across 9 distinct tickers has a 60% success rate on the captured sample, covering both identified sources.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| NVS | 2026-03-26 | buy | $170.00 | Aggregated |
| SNY | 2025-09-08 | buy | $58.00 | Aggregated |
| AZN | 2024-01-23 | buy | $85.00 | Aggregated |
| AZNASTRAZENECA PLC - ADR | 2024-01-23 | unknown | $85.00 | Aggregated |
| GSK | 2024-01-23 | unknown | $44.00 | Aggregated |
| GSKGSK PLC - ADR | 2024-01-23 | unknown | $44.00 | Aggregated |
| NVONOVO NORDISK - ADR | 2024-01-23 | unknown | $120.00 | Aggregated |
| NVS | 2024-01-23 | unknown | $114.00 | Aggregated |
| NVSNOVARTIS AG - ADR | 2024-01-23 | unknown | $114.00 | Aggregated |
| SNY | 2024-01-23 | unknown | $55.00 | Aggregated |
| SNYSANOFI - ADR | 2024-01-23 | unknown | $55.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| NVS | 2 | 2026-03-26 | Aggregated |
| SNY | 2 | 2025-09-08 | Aggregated |
| AZN | 1 | 2024-01-23 | Aggregated |
| AZNASTRAZENECA PLC - ADR | 1 | 2024-01-23 | Aggregated |
| GSK | 1 | 2024-01-23 | Aggregated |
| GSKGSK PLC - ADR | 1 | 2024-01-23 | Aggregated |
| NVONOVO NORDISK - ADR | 1 | 2024-01-23 | Aggregated |
| NVSNOVARTIS AG - ADR | 1 | 2024-01-23 | Aggregated |
| SNYSANOFI - ADR | 1 | 2024-01-23 | Aggregated |